Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,140 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

UPLYFT For Lymphoma Survivors

NCT05080166

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

NCT06831370

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • HCG City Cancer Centre Vijayawada, Andhra Pradesh, India
  • Gauhati Medical college and Hospital Guwahati, Assam, India
  • Unique Hospital Multispeciality and Research Institute Surat, Gujarat, India
  • HCG Cancer Centre Bangalore, Karnataka, India
View Trial Details
Recruiting

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

NCT06854003

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Epco, Zanu, Ritux for R/R FL or MZL

NCT06563596

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Recruiting

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

NCT07018752

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Institut d'Hématologie de Basse Normandie - Service Hématologie (CHU Hôpital Côte de Nacre) Caen, France
  • CHU Estaing - Service Thérapie Cellulaire et Hématologie Clinique Clermont-Ferrand, France
  • Hôpital Henri Mondor - Unité Hémopathies Lymphoïdes Créteil, France
  • CHU Dijon Bourgogne - Service Hématologie Clinique Dijon, France
View all 20 locations
View Trial Details

Related conditions